Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.
about
Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participateAre all ICUs the same?Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study.On cancer control and the adolescentCancer registration: its uses in research, and confidentiality in the EC.Therapeutic trials in childhood ALL: what's their future?Electronic clinical trial protocol distribution via the World-Wide Web: a prototype for reducing costs and errors, improving accrual, and saving trees.The breast cancer research scandal: addressing the issues.Improving care for central nervous system tumours: a mood for change.Survival after acute lymphocytic leukaemia: effects of socioeconomic status and geographic region.Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994.Long term survival and cure after childhood cancerTrends in survival for childhood cancer in Britain diagnosed 1971-85Disparities in cancer outcomes: lessons learned from children with cancerManagement of ovarian cancer: referral to a multidisciplinary team matters.Centralised treatment, entry to trials and survival.Access to principal treatment centres and survival rates for children and young people with cancer in Yorkshire, UK.Continued inadequacies in data sources for the evaluation of cancer servicesPatterns of care and survival for adolescents and young adults with acute leukaemia--a population-based study.Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer: response and survival resultsHaematology.Population based survival rates for childhood cancer in Britain, 1980-91.Volume-Outcome Relationships in Pediatric Acute Lymphoblastic Leukemia: Association Between Hospital Pediatric and Pediatric Oncology Volume With Mortality and Intensive Care Resources During Initial Therapy.Barriers and facilitators for clinical trial participation among diverse Asian patients with breast cancer: a qualitative study.Comparison of survival outcomes among cancer patients treated in and out of clinical trials.Cancer in Australian Aboriginal children: room for improvement.The volume effect in paediatric oncology: a systematic review.The changing face of paediatric oncology.Soft tissue sarcoma--compliance with guidelines.An audit of the activities of the paediatric oncology unit in Edinburgh, 1982-1991.School refusal and truancy.Survival of patients with cancerTreatment protocols, specialist centers, and end results.Gaining patients' consent. Telling parents all relevant details might reduce recruitment of children to trials.In this issue/abstract thinking: treatment response in psychiatry.High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from China.Clinical trial participation among patients enrolled in the Glioma Outcomes Project.Association of clinical trial enrollment and survival using contemporary therapy for pediatric acute lymphoblastic leukemia.Incidence, socioeconomic deprivation, volume-outcome and survival in adult patients with acute lymphoblastic leukaemia in England.Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials.
P2860
Q24242288-7B7FB796-ADDE-4A01-B051-09F7080326C9Q27010359-2C126554-96D4-422F-887F-912F52E28001Q33624440-A928AD61-9DF9-4397-BBEF-6AE4970A0CA1Q33652428-4019CB33-6B2A-4CDA-A8E6-4862C3741B2FQ33701970-2077AD85-B458-4B78-BA31-FB654FE3B746Q33893055-CF4B88C5-6B18-4F62-B8CF-AEC46E83AAEAQ33950512-5D92874D-6C8D-43DE-AFDA-961A7A3382EEQ34278939-337C3264-FD35-49EE-8CDD-08576B05058FQ35254496-ED55114F-5B26-4011-B9B1-0BB2739E66B0Q35262797-6C432A08-C1C5-4AFD-94D8-1CEB2A66B4F4Q35264729-726F1063-EBBC-4B9B-9966-EB1339EF0387Q35625681-B9C91002-27F3-4177-97A3-7575AFE61FC8Q35982185-43698C97-D615-4123-8D0D-4C492654BE5FQ36015045-EA57B38C-5584-430C-96B9-A8D2F5225B35Q36079950-7C6E8B7D-8B1B-483F-8CFA-871704FB70E6Q36079975-F58180A0-D6CD-4186-ADE6-88D4030BC6AFQ36296966-44E828EC-C0D9-4868-AE1A-6959735ED61DQ36419917-B574FC17-010C-4A51-9B63-CDC2A5F1CDA4Q36618262-5D28595D-B13B-4A48-B802-9C16190F9CCFQ36646034-5C4770D3-6E1E-4EE2-B71F-D7333F687529Q36723863-259D858C-AAF3-46D6-9CAB-2F8A7C6D0D5EQ36888836-80C343E1-C1A0-4CF7-865A-8A4D27A81FF3Q37047687-EE1557C8-2934-4DE0-B98C-DFB47A319C45Q37119507-215C611D-E82E-495E-9DA5-085FF2C75A73Q37696455-3C27D3CF-C730-4DCD-8237-17A8CD680D91Q38063923-E01200F9-D836-4059-890E-77165514FD91Q38078913-D846B110-F5E3-44D4-A112-6A38126F1C17Q40427103-CCE0BF86-2E03-4291-BFC2-0C71359F2A04Q40704102-6F3F314A-B4BD-4991-AB79-3318C3E12DAEQ40837674-5B127B50-A027-4F25-87DC-A19742074624Q41889529-C824B302-2BE2-4BBF-902F-E7BF40D7E327Q42114148-30B96FDF-9054-4232-B2B8-A7D80932A965Q43177044-BFD6AA9F-AF02-48C4-96AC-5F525CC94467Q43189114-6152AA40-AE1F-4346-B4A8-918125834310Q43228720-D10E19DB-1C72-4A1C-AD9F-9F3BA1D91AACQ45105047-B417F6B2-ED64-4193-B3C6-38CA9D853538Q45972500-0BE776E6-340E-42F3-B89D-513E1406EAB6Q46868442-36C221E7-3747-4C7C-A78D-26100627CCFFQ47208658-2DA92C7F-2D6D-426F-9C84-45DE0A1A2EA5Q47368648-7B24C20B-3F69-4095-85A2-EFD7A1E600FC
P2860
Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.
@ast
Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.
@en
type
label
Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.
@ast
Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.
@en
prefLabel
Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.
@ast
Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.
@en
P2860
P356
P1476
Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.
@en
P2093
P2860
P304
P356
10.1136/ADC.64.5.657
P407
P577
1989-05-01T00:00:00Z